Bizelesin
Term · Oncology and biomedicine · MLC-T-ONC-001094
An anticancer drug that belongs to the family of drugs called alkylating agents. It is also an antitumor antibiotic.
A synthetic cyclopropylpyrroloindole antineoplastic antibiotic. Bizelesin binds to the minor groove of DNA and induces interstrand cross-linking of DNA, thereby inhibiting DNA replication and RNA synthesis. Bizelesin also enhances p53 and p21 induction and triggers G2/M cell-cycle arrest, resulting in cell senescence without apoptosis.
| Identifier | MLC-T-ONC-001094 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-001094",
"term": "Bizelesin",
"field": "Oncology and biomedicine",
"definitions": [
"An anticancer drug that belongs to the family of drugs called alkylating agents. It is also an antitumor antibiotic.",
"A synthetic cyclopropylpyrroloindole antineoplastic antibiotic. Bizelesin binds to the minor groove of DNA and induces interstrand cross-linking of DNA, thereby inhibiting DNA replication and RNA synthesis. Bizelesin also enhances p53 and p21 induction and triggers G2/M cell-cycle arrest, resulting in cell senescence without apoptosis."
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/bizelesin/"
}
Record 3,637 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.